161 related articles for article (PubMed ID: 9289681)
1. [Data on cholesterol level screening of patients with ischemic heart disease in the light of the Scandinavian Simvastatin Survival Study].
Márk L; Kondacs A; Hanyecz V; Simondán G
Orv Hetil; 1997 Jun; 138(26):1679-82. PubMed ID: 9289681
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.
Johannesson M; Jönsson B; Kjekshus J; Olsson AG; Pedersen TR; Wedel H
N Engl J Med; 1997 Jan; 336(5):332-6. PubMed ID: 9011785
[TBL] [Abstract][Full Text] [Related]
3. [The Scandinavian Simvastatin Survival Study: the clinical consequences].
Larsen ML
Rev Esp Cardiol; 1995; 48 Suppl 5():39-42. PubMed ID: 7494939
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment.
Wilhelmsen L; Pyörälä K; Wedel H; Cook T; Pedersen T; Kjekshus J
Eur Heart J; 2001 Jul; 22(13):1119-27. PubMed ID: 11428852
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study.
Pedersen TR; Berg K; Cook TJ; Faergeman O; Haghfelt T; Kjekshus J; Miettinen T; Musliner TA; Olsson AG; Pyörälä K; Thorgeirsson G; Tobert JA; Wedel H; Wilhelmsen L
Arch Intern Med; 1996 Oct; 156(18):2085-92. PubMed ID: 8862101
[TBL] [Abstract][Full Text] [Related]
6. [Current developments in prevention of coronary heart disease].
Windler E
Z Arztl Fortbild (Jena); 1996 Feb; 90(1):7-10. PubMed ID: 8650967
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the lowering effect on blood cholesterol of clofibrate and simvastatin].
Gavelli MS; Vitaliano E; Serra T; Rossi FG; Rizzuti A; Caridis R; Tozzi J
Clin Ter; 1990 May; 133(3):145-50. PubMed ID: 2142901
[TBL] [Abstract][Full Text] [Related]
8. Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study).
Garmendia F; Brown AS; Reiber I; Adams PC
Curr Med Res Opin; 2000; 16(3):208-19. PubMed ID: 11191012
[TBL] [Abstract][Full Text] [Related]
9. Profiling a landmark clinical trial: Scandinavian Simvastatin Survival Study.
Guptha S
Curr Opin Lipidol; 1995 Oct; 6(5):251-3. PubMed ID: 8520845
[No Abstract] [Full Text] [Related]
10. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
11. [Hypercholesterolemia in the aged: rational approach to the problem].
Antonicelli R; Lipponi G; Cadeddu G; Gaetti R
Clin Ter; 1990 Aug 15-31; 134(3-4):173-80. PubMed ID: 2147617
[TBL] [Abstract][Full Text] [Related]
12. Scandinavian simvastatin study (4S).
Grodos D; Tonglet R
Lancet; 1994 Dec 24-31; 344(8939-8940):1768. PubMed ID: 7997017
[No Abstract] [Full Text] [Related]
13. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
Lancet; 1994 Nov; 344(8934):1383-9. PubMed ID: 7968073
[TBL] [Abstract][Full Text] [Related]
14. [The Scandinavian Simvastatin Survival Study].
Faergeman O; Haghfelt T
Ugeskr Laeger; 1995 Jan; 157(4):458-60. PubMed ID: 7846795
[No Abstract] [Full Text] [Related]
15. Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies.
Gresser U; Gathof BS
Eur J Med Res; 2004 Jan; 9(1):1-17. PubMed ID: 14766335
[TBL] [Abstract][Full Text] [Related]
16. [Lowering LDL cholesterol with Simvastatin. Also, economically reasonable!].
Internist (Berl); 1995 Aug; 36(8 Suppl):1-4. PubMed ID: 9131077
[No Abstract] [Full Text] [Related]
17. Which statin is most efficient for the treatment of hypercholesterolemia? A cost-effectiveness analysis.
Cobos A; Jovell AJ; García-Altés A; García-Closas R; Serra-Majem L
Clin Ther; 1999 Nov; 21(11):1924-36. PubMed ID: 10890264
[TBL] [Abstract][Full Text] [Related]
18. [Treatment with statins: further data from the Heart Protection Study].
Tonstad S; Holme I
Tidsskr Nor Laegeforen; 2002 Nov; 122(29):2777-80. PubMed ID: 12523144
[TBL] [Abstract][Full Text] [Related]
19. [The 4-S study--a turning point in the cholesterol debate. Work Group Lipids and Atherosclerosis of the Swiss Society for Cardiology].
Nigg C
Praxis (Bern 1994); 1995 Dec; 84(51-52):1514-6. PubMed ID: 8571010
[No Abstract] [Full Text] [Related]
20. [Effect of medicamentous cholesterol control on resources utilization in public health--significance of the Scandinavian Simvastatin Survival Study (4-S Study) for cost control in Swiss health management conditions].
Szucs TD; Lüscher TF; Gutzwiller F
Schweiz Med Wochenschr; 1997 Nov; 127(44):1819-23. PubMed ID: 9446200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
